Fresenius 腹膜透析液因主袋微孔泄漏风险自主召回,FDA 记录 D-0170-2027 定为 Class II
FDA drug enforcement D-0170-2027: Fresenius Medical Care Renal Therapies Group, LLC — Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
FDA 执法报告记录 Fresenius Medical Care 肾治疗集团自主召回 DELFLEX 2.5% 葡萄糖低镁低钙腹膜透析液,召回编号 D-0170-2027,定为 Class II。
记录列出泄漏投诉所涉腹膜透析液的具体批号、数量与分销范围,可供核对本次召回边界与无菌保证问题的关联。
FDA 药品召回执行报告 — D-0170-2027
报告发布日期:2026-11-11。这是执行报告日期,不是召回启动日期。
范围:一条已分类的药品召回记录;event_id 可能归组多个产品。没有召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。
openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所表示的含义。
完整官方产品记录(包括 openFDA 统一标识符):
{
"address_1": "350 Merrimack St",
"address_2": "",
"center_classification_date": "20261103",
"city": "Lawrence",
"classification": "Class II",
"code_info": "批号:25JGPD069,有效期至 2027/1/31;25SGPD046、25SGPD059、25SGPD063,有效期至 2027/6/30;26EGPD022,有效期至 2027/11/30。",
"country": "United States",
"distribution_pattern": "美国全国范围。",
"event_id": "100130",
"initial_firm_notification": "信函",
"more_code_info": "",
"openfda": {
"application_number": [
"NDA020171"
],
"brand_name": [
"DELFLEX"
],
"generic_name": [
"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"
],
"is_original_packager": [
true
],
"manufacturer_name": [
"Fresenius Medical Care de Mexico, S.A. de C.V."
],
"package_ndc": [
"46163-209-92",
"46163-209-94",
"46163-209-95",
"46163-212-95",
"46163-212-92",
"46163-212-94",
"46163-206-92",
"46163-206-94",
"46163-206-95"
],
"product_ndc": [
"46163-206",
"46163-209",
"46163-212"
],
"product_type": [
"HUMAN PRESCRIPTION DRUG"
],
"route": [
"INTRAPERITONEAL"
],
"spl_id": [
"5f14959c-adcd-923c-e063-6294a90ab6de"
],
"spl_set_id": [
"a98facd6-9daa-4d37-8209-63a0599dbfaa"
],
"substance_name": [
"DEXTROSE MONOHYDRATE",
"SODIUM CHLORIDE",
"SODIUM LACTATE",
"CALCIUM CHLORIDE",
"MAGNESIUM CHLORIDE"
],
"unii": [
"TU7HW0W0QT",
"LX22YL083G",
"02F3473H9O",
"451W47IQ8X",
"M4I0D6VV5M"
]
},
"postal_code": "01843-1748",
"product_description": "DELFLEX 腹膜透析液,含 2.5% 葡萄糖,低镁/低钙,附带 stay\"safe 交换管路,2,500 mL 单剂量袋,无菌且无热原,仅限处方,CAT. NO. 054-25322。Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843。NDC 46163-209-94",
"product_quantity": "2,709 箱(每箱 5 袋)",
"product_type": "药品",
"reason_for_recall": "无菌保证不足:已收到投诉,涉及受影响批次主袋印刷区域的小穿孔可能导致泄漏。",
"recall_initiation_date": "20261014",
"recall_number": "D-0170-2027",
"recalling_firm": "Fresenius Medical Care Renal Therapies Group, LLC",
"report_date": "20261111",
"state": "MA",
"status": "进行中",
"voluntary_mandated": "自愿:企业发起"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov